Effects of ultrasound-guided maxillary nerve block on QoR-40 in patients undergoing endoscopic sinus surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023586

Enrollment

Unknown

Registered

2019-06-03

Start date

2019-06-15

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia and otolaryngology, head and neck diseases--Rhinology disease

Interventions

NB:ultrasound-guided maxillary nerve block

NC:control group

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA I ~ II, aged 18 ~ 65 years old, without coagulation dysfunction, Scheduled for septal and/or sinus surgery under endoscopy.

Exclusion criteria

Exclusion criteria: Unable to complete the study, or were unwilling to participate; with anticoagulant or antiplatelet treatment; with neurological disorders; with moderate to severe hypertension (BP=160/100mmHg); with ischemic cardiovascular and cerebral vascular diseases.

Design outcomes

Primary

Measure	Time frame
QoR-40;QoR-40;total consumption of morphine 48h post-operation;	—

Secondary

Measure	Time frame
consumption of remifentanil;consumption of propofol;eye open time;extubation time;periextubation adverse events;duration of modified Aldrete score reaches 10;NRS pain score in PACU;duration in PACU;VAS score of PONV in PACU;other adverse events in PACU;rescue analgesia in PACU;antiemetic in PACU;NRS pain scores post-operation in ward;PONV VAS score in ward;rescue analgesia in ward;time to first analgesic requirement of PCA;other postoperative adverse events in ward;	—

Measure

Time frame

consumption of remifentanil;consumption of propofol;eye open time;extubation time;periextubation adverse events;duration of modified Aldrete score reaches 10;NRS pain score in PACU;duration in PACU;VAS score of PONV in PACU;other adverse events in PACU;rescue analgesia in PACU;antiemetic in PACU;NRS pain scores post-operation in ward;PONV VAS score in ward;rescue analgesia in ward;time to first analgesic requirement of PCA;other postoperative adverse events in ward;

—

Countries

China

Contacts

Public ContactLiu Jinsheng

Department of Anesthesiology, Beijing Tongren Hospital, Capital Medical University

jinshengliu777@163.com+86 010 58268105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026